Australia Markets — Midday Update: ASX 200 Tracks Wall Street Lower as RBA Minutes Released (Nov 17, 2026)

Photo: Mikecligon / Wikimedia Commons (CC0)

The Library Media — Business & Markets · Markets Desk

Australia Markets — Midday Update: ASX 200 Tracks Wall Street Lower as RBA Minutes Released (Nov 17, 2026)

By Clara Ledger

Share

Published November 16, 2026 · 6:34 PM PT · Updated November 17, 2026 · 1:28 PM PT

Photo: Mikecligon / Wikimedia Commons (CC0)

The S&P/ASX 200 stood at 8,918.50, down 126.20 points, or 1.40%, as of 12:53:44 p.m. AEDT on Tuesday, Nov. 17, according to Yahoo Finance’s delayed quote. The Australian Securities Exchange, in Sydney, Australia, trades from 10:00 a.m. to 4:00 p.m. AEDT. Individual share moves below are Tuesday intraday figures from StockAnalysis, observed at about 1:11 p.m. AEDT, in Australian dollars.

Biggest gainers

MEC Resources Limited (MMR) +100.00% 0.0020 AUD — No confirmed driver reported for this move.

Mayne Pharma Group Limited (MYX) +86.60% 5.99 AUD — Hungarian drugmaker Gedeon Richter agreed to acquire Mayne Pharma for about A$604 million in cash, or approximately US$407 million-US$408 million, at A$6.40 a share. The offer represents a 99.4% premium to Monday’s A$3.21 close, according to reports from Reuters, the Australian Financial Review and Investing.com on Nov. 16-17.

Imagion Biosystems Limited (IBX) +50.00% 0.0060 AUD — No confirmed driver reported for this move.

Biggest losers

Ausmon Resources Limited (AOA) -33.33% 0.0010 AUD — No confirmed driver reported for this move.

Enova Mining Limited (ENV) -33.33% 0.0010 AUD — No confirmed driver reported for this move.

Ovanti Limited (OVT) -33.33% 0.0010 AUD — No confirmed driver reported for this move. Terrain Minerals also fell 33.33%, tying for fourth in the supplied ranking.

The ASX 200 was down about 1.4% around midday, tracking Monday’s Wall Street decline. The Reserve Bank of Australia released minutes of its November board meeting on Tuesday. Reuters reported that a majority of members judged a rate hike was needed in November as inflation pressures persisted. Mayne Pharma was a standout against the broader market decline after the Gedeon Richter cash acquisition agreement. No confirmed company-specific explanation was supplied for the other listed movers.

Clara Ledger
Markets Desk, The Library Media

From The Library — the estate of our family.

Follow Us

X Facebook Instagram Threads Mastodon Bluesky

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top